| Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring AE Rizzardi, AT Johnson, RI Vogel, SE Pambuccian, J Henriksen, ... Diagnostic pathology 7, 1-10, 2012 | 511 | 2012 |
| Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ... Cancer discovery 3 (6), 674-689, 2013 | 116 | 2013 |
| Evaluation of protein biomarkers of prostate cancer aggressiveness AE Rizzardi, NK Rosener, JS Koopmeiners, R Isaksson Vogel, ... BMC cancer 14, 1-14, 2014 | 86 | 2014 |
| Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1 SH Isakson, AE Rizzardi, AW Coutts, DF Carlson, MN Kirstein, J Fisher, ... Communications biology 1 (1), 158, 2018 | 68 | 2018 |
| Elevated hyaluronan and hyaluronan‐mediated motility receptor are associated with biochemical failure in patients with intermediate‐grade prostate tumors AE Rizzardi, RI Vogel, JS Koopmeiners, CL Forster, LO Marston, ... Cancer 120 (12), 1800-1809, 2014 | 55 | 2014 |
| CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy L Ding, S Chen, P Liu, Y Pan, J Zhong, KM Regan, L Wang, C Yu, ... Cancer research 74 (7), 2050-2061, 2014 | 55 | 2014 |
| The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin A Srirangam, M Milani, R Mitra, Z Guo, M Rodriguez, H Kathuria, ... Journal of Thoracic Oncology 6 (4), 661-670, 2011 | 54 | 2011 |
| Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors PJ Beckmann, JD Larson, AT Larsson, JP Ostergaard, S Wagner, ... Cancer research 79 (5), 905-917, 2019 | 50 | 2019 |
| Safe and effective sarcoma therapy through bispecific targeting of EGFR and uPAR A Borgatti, JS Koopmeiners, AL Sarver, AL Winter, K Stuebner, ... Molecular cancer therapeutics 16 (5), 956-965, 2017 | 50 | 2017 |
| Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer AE Rizzardi, X Zhang, RI Vogel, S Kolb, MS Geybels, YK Leung, ... Diagnostic pathology 11, 1-11, 2016 | 43 | 2016 |
| Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides GJ Metzger, SC Dankbar, J Henriksen, AE Rizzardi, NK Rosener, ... PloS one 7 (3), e33520, 2012 | 33 | 2012 |
| Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis EP Rahrmann, BS Moriarity, GM Otto, AL Watson, K Choi, MH Collins, ... The American journal of pathology 184 (7), 2082-2098, 2014 | 30 | 2014 |
| Canonical Wnt/β-catenin signaling drives human Schwann cell transformation, progression, and tumor maintenance. Cancer Discov. 2013; 3: 674–689. doi: 10.1158/2159-8290 AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ... Cell 152 (5), 1077-90, 2013 | 23 | 2013 |
| Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant … DM Seelig, D Ito, CL Forster, UA Yoon, M Breen, LJ Burns, V Bachanova, ... Leukemia & lymphoma 58 (7), 1702-1710, 2017 | 16 | 2017 |
| Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E-and IHC-stained histopathological specimens E Leng, JC Henriksen, AE Rizzardi, J Jin, JW Nam, BM Brassuer, ... Scientific reports 9 (1), 6992, 2019 | 11 | 2019 |
| Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma B Charbonneau, RI Vogel, JC Manivel, A Rizzardi, SC Schmechel, ... Human pathology 44 (9), 1918-1926, 2013 | 7 | 2013 |
| Elevated HA and HMMR are associated with biochemical failure in patients with intermediate grade prostate tumors AE Rizzardi, RI Vogel, JS Koopmeiners, CL Forster, LO Marston, ... Cancer 120 (12), 1800, 2014 | 5 | 2014 |
| Genetically engineered minipigs model the major clinical features of human SH Isakson, AE Rizzardi, AW Coutts Communications, 2018 | | 2018 |
| Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4 N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ... LABORATORY INVESTIGATION 95, 254A-254A, 2015 | | 2015 |
| Quantification of Tumor Heterogeneity in Whole Slide Images of Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4 N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ... MODERN PATHOLOGY 28, 254A-254A, 2015 | | 2015 |
